[ET Net News Agency, 25 September 2019] Shanghai Henlius Biotech, Inc. (02696) closed
at HK$48.5, or 2.22% lower than its offer price of HK$49.6, on PhillipMart, an automated
electronic platform for pre-IPO shares trading, according to Phillip Securities.
The total trading volume reached 128,500 shares with a total value of HK$6.22 million.
(KL)